Anika Therapeutics, Inc. · Class II · Cleared Aug 31, 2021
| K-number | K212083 |
| Device name | Tactoset Injectable Bone Substitute |
| Applicant | Anika Therapeutics, Inc. |
| Product code | MQV |
| Device class | Class II |
| Decision date | Aug 31, 2021 |
| Decision | Substantially Equivalent |
| Regulation | 888.3045 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov